Imatinib Mesylate 400 mg/1 (Imatinib Mesylate TABLET) 400 mg/1

Imatinib mesylate 400 mg tablets are a prescription medication used to treat certain types of cancer. This oral treatment is designed to target specific proteins involved in cancer cell growth. Learn more about its uses and effects.

Strength

400 mg/1

Pack Size

30 TABLET in 1 BOTTLE (0832-0533-03)

Manufacturer / TM Owner

Upsher-Smith Laboratories, LLC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Imatinib mesylate is primarily used in the treatment of various types of cancer, including chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GIST). It works by inhibiting the growth of cancer cells. Patients often wonder, 'What is imatinib mesylate used for?' This medication is specifically formulated to target and interfere with the growth of cancer cells, making it a crucial part of cancer treatment protocols.

Side Effects

Common effects of imatinib mesylate may include nausea, vomiting, muscle cramps, and swelling. Some users may also experience fatigue or skin rashes. These effects can vary from person to person, and it's important to consult a healthcare provider for personalized advice.

Precautions & Warnings

Imatinib mesylate should be handled with care and stored as directed. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. Always inform your doctor about any other medications you are taking to avoid potential interactions.

Avoid Interactions

Imatinib mesylate may interact with certain medications, including those that are metabolized by the liver. It is advisable to avoid grapefruit and grapefruit juice, as they can affect the metabolism of this medication. Always consult a healthcare provider before starting or stopping any medication.

Frequently Asked Questions

Imatinib mesylate is used to treat certain types of cancer, such as chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GIST).

Imatinib mesylate is typically taken orally, with or without food, as directed by a healthcare provider.

Common side effects may include nausea, vomiting, muscle cramps, and fatigue. Always consult a healthcare provider for personalized advice.

Imatinib mesylate may interact with certain medications, so it's important to consult a healthcare provider before combining it with other treatments.

The safety of imatinib mesylate during pregnancy has not been established. Consult a healthcare provider for personalized advice.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.